CEACAM based antibacterial agents
OwnerGal Markelinventor
Life of this patent
Estimating the term…
Abstract
Prophylactic and/or therapeutic antipathogen agents are provided that disrupt or prevent the formation of at least one homotypic and/or heterotypic protein-protein interaction that has at least one CEA-family protein and that is involved in the establishment and colonization of a pathogen in a suitable host.
Claims3
A multimer therapeutic agent consisting of two different isolated peptides selected from the group consisting of SEQ ID No. 21 SEQ ID No. 24.
A multimer therapeutic agent consisting of the isolated peptides NRQIV (SEQ ID No. 21) and QNDTG (SEQ ID No. 23).
A multimer therapeutic agent consisting of the isolated peptides NRQIV (SEQ ID No. 21) and GYSWYK (SEQ ID. No. 24).
Dependencies are inferred from the claim text.